Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.20.2
Shareholders' Deficit (Tables)
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of nonvested activity
    Number of
Non-vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2019     17,675,299     $ 0.23  
Granted     7,450,000       0.04  
Shares vested     (1,273,373 )     (0.41 )
Non-vested, June 30, 2020     23,851,926     $ 0.16  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price     Weighted
Average
Remaining
Contractual Term (Years)		     Aggregate Intrinsic
Value		  
Balance Outstanding, December 31, 2019     8,445,698     $ 0.40                                   
Granted     -       -                  
Forfeited     -       -                  
Balance Outstanding, June 30, 2020     8,445,698     $ 0.40       5.69     $ 0  
Exercisable, June 30, 2020     8,152,547     $ 0.41       5.63     $ 0  
Schedule of warrant activities
    Number of Warrants     Weighted Average Exercise Price     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate Intrinsic
Value		  
Balance Outstanding December 31, 2019     2,050,000     $ 0.10                 -     $ -  
Granted     288,750       0.003                  
Cancelled     -       -                  
Balance Outstanding June 30, 2020     2,338,750     $ 0.04       4.23     $ 11,848  
Exercisable, June 30, 2020     2,338,750     $ 0.04       4.23     $ 11,848